NCT01582919View on ClinicalTrials.gov

Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study

NACompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
DementiaAlzheimer Disease
Interventions
OTHER

Neuroimaging

Trial Locations (1)

33000

Groupe Hospitalier Pellegrin - C.H.U. de Bordeaux, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT01582919 - Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study | Biotech Hunter | Biotech Hunter